161 related articles for article (PubMed ID: 12790323)
1. Minimal residual disease in gastric cancer.
Seeliger H; Spatz H; Jauch KW
Recent Results Cancer Res; 2003; 162():79-87. PubMed ID: 12790323
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of bone marrow micrometastases in patients with gastric cancer.
Jauch KW; Heiss MM; Gruetzner U; Funke I; Pantel K; Babic R; Eissner HJ; Riethmueller G; Schildberg FW
J Clin Oncol; 1996 Jun; 14(6):1810-7. PubMed ID: 8656249
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
4. [Tumor cell dissemination in bone marrow and peritoneal cavity. An immunocytochemical study of patients with stomach or colorectal carcinoma].
Broll R; Lembcke K; Stock C; Zingler M; Duchrow M; Schimmelpenning H; Strik M; Muller G; Kujath P; Bruch HP
Langenbecks Arch Chir; 1996; 381(1):51-8. PubMed ID: 8717176
[TBL] [Abstract][Full Text] [Related]
5. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer.
Passlick B; Kubuschok B; Izbicki JR; Thetter O; Pantel K
Ann Thorac Surg; 1999 Dec; 68(6):2053-8. PubMed ID: 10616976
[TBL] [Abstract][Full Text] [Related]
6. The presence of bone marrow cytokeratin-immunoreactive cells does not predict outcome in gastric cancer patients.
de Manzoni G; Pelosi G; Pavanel F; Di Leo A; Pedrazzani C; Durante E; Cordiano C; Pasini F
Br J Cancer; 2002 Apr; 86(7):1047-51. PubMed ID: 11953846
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of microscopic peritoneal dissemination: comparison between colon and gastric cancer.
Vogel P; Rüschoff J; Kümmel S; Zirngibl H; Hofstädter F; Hohenberger W; Jauch KW
Dis Colon Rectum; 2000 Jan; 43(1):92-100. PubMed ID: 10813130
[TBL] [Abstract][Full Text] [Related]
8. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease in gastric cancer: evidence of an independent prognostic relevance of urokinase receptor expression by disseminated tumor cells in the bone marrow.
Heiss MM; Simon EH; Beyer BC; Gruetzner KU; Tarabichi A; Babic R; Schildberg FW; Allgayer H
J Clin Oncol; 2002 Apr; 20(8):2005-16. PubMed ID: 11956259
[TBL] [Abstract][Full Text] [Related]
10. Are "micrometastases" of the peritoneum equivalent to distant metastases?
Kienle P; Koch M
Dig Surg; 2002; 19(6):453-8. PubMed ID: 12499736
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma.
Thorban S; Roder JD; Nekarda H; Funk A; Siewert JR; Pantel K
J Natl Cancer Inst; 1996 Sep; 88(17):1222-7. PubMed ID: 8780632
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemically detected micrometastases of the lymph nodes in patients with gastric carcinoma.
Fukagawa T; Sasako M; Mann GB; Sano T; Katai H; Maruyama K; Nakanishi Y; Shimoda T
Cancer; 2001 Aug; 92(4):753-60. PubMed ID: 11550144
[TBL] [Abstract][Full Text] [Related]
13. [Micrometastasis in Gastric Cancer].
Youn GJ; Chung WC
Korean J Gastroenterol; 2017 May; 69(5):270-277. PubMed ID: 28539031
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
16. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
17. Lymph node revealing solution in gastric carcinoma does not provide upstaging of the N-status.
Luebke T; Baldus SE; Zirbes TK; Pham TD; Schneider PM; Dienes HP; Hölscher AH; Mönig SP
Oncol Rep; 2005 Feb; 13(2):361-5. PubMed ID: 15643525
[TBL] [Abstract][Full Text] [Related]
18. Immunocytology improves prognostic impact of peritoneal tumour cell detection compared to conventional cytology in gastric cancer.
Vogel P; Rüschoff J; Kümmel S; Zirngibl H; Hofstädter F; Hohenberger W; Jauch KW
Eur J Surg Oncol; 1999 Oct; 25(5):515-9. PubMed ID: 10527600
[TBL] [Abstract][Full Text] [Related]
19. Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus.
Janni W; Hepp F; Strobl B; Rack B; Rjosk D; Kentenich C; Schindlbeck C; Hantschmann P; Pantel K; Sommer H; Braun S
Cancer; 2003 Jan; 97(2):405-11. PubMed ID: 12518364
[TBL] [Abstract][Full Text] [Related]
20. Microscopic tumor cell dissemination in gastric cancer.
Jonas S; Weinrich M; Tullius SG; Al-Abadi H; Steinbrich R; Radke C; Klupp J; Neuhaus P
Surg Today; 2004; 34(2):101-6. PubMed ID: 14745607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
